Research Paper Volume 15, Issue 11 pp 4963—4985
FDX1 serves as a prognostic biomarker and promotes glioma progression by regulating the immune response
Figure 1. General information regarding FDX1. (A) Expression distribution of FDX1 in brain tissue. (B) FDX1 expression is higher in the tumor tissue than in normal tissue. (C) Comparison of FDX1 expression among different copy number variations. (D) FDX1 alteration frequency by glioma subtype. (E) Subcellular location of FDX1. (F) Immunofluorescence images of FDX1 protein, nucleus, endoplasmic reticulum, microtubules, and merged images in U251 cells.